If there were PK/PD issues with fosfo, the problem might arise not on early TOC, but on relapses of non-cystitis UTI.
In this subanalysis of patients switched to oral in FOREST trial, more relapses were observed with fosfo for bacteremic E. coli UTI.
academic.oup.com/jac/article/... #IDSky #UTIsky
